Direct and Indirect Effects of Human Recombinant 7-Interferon on Tumor Cells in a Clonogenic Assay

Cancer Research

Volumn 46, Issue 3, 1986, Pages 1142-1147

  Saito, Toshiaki ^a   Berens, Michael E ^a   Welander, Charles E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

BREAST; CLONOGENIC ASSAY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RESPONSE; FEMALE GENITAL SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; INTOXICATION; KIDNEY; LYMPHATIC SYSTEM; MACROPHAGE; MACROPHAGE ACTIVATION; METHODOLOGY; MOUSE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TUMOR CELL LINE;

CELL CYCLE; CELL LINE; GROWTH INHIBITORS; HUMAN; IMMUNOTHERAPY; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MACROPHAGES; NEOPLASMS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0022553450     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wheelock, E. F. Interferon–like virus inhibitor induced in human lymphocytes by phytohemagglutinin. Science (Wash. DC), 769: 310-311,1965.
2. Blalock, J. E., Georgiades, J. A., Langford, M. P., and Johnson, H. M. Purified human immune interferon has more potent anticellular activity than fibroblasts or leukocyte interferon. Cell. Immunol., 49: 390-394,1980.
3. Johnson, H. M. Cellular regulation of immune interferon production. Antiviral Res., 7: 37-41, 1981.
4. Herberman, R. B. Interferons and cytotoxic effector cells. In: J. Vilcek and E. De Maeyer (eds.), Interferons, Vol. 2, Interferons and the Immune System, pp. 61-80. Amsterdam: Elsevier, 1984.
5. Schreiber, R. D. Identification of–Hnterferon as a murine macrophage activating factor for tumor cytotoxicity. Contemp. Top. Immunobiol., 73: 171-197,1984.
6. Nathan, C. F., Prendergast, T. J., Wiebe, M. E., Stanley, E. R., Platzer, E., Remold, H. G., Weltek, K., Rubin, B. Y., and Murray, H. W. Activation of human macrophages: comparison of other cytokines with interferon-7. J. Exp. Med., 760:600-605, 1984.
7. Fleishmann, W. R. Potentiation of direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. Cancer Res. 42:869-875, 1982.
8. Ito, M., and Buffet, R. F. Cytocidal effect of purified human fibrotrtast interferon on tumor cells in vitro. J. Nati. Cancer Inst., 66: 819-825,1981.
9. Salmon, S. E. Application of the human tumor stem cell assay to new drug evaluation and screening. In: S. E. Salmon (ed.), Cloning of Human Tumor Stem Cells, pp. 291-312. New York: Alan R. Liss, Inc., 1980.
10. Ludwig, C. U., Dune, B. G. M., Salmon, S. E., and Moon, T. E. Effect of leukocyte interferons on cell proliferation of human tumors in vitro. In: V. Hofmann, M. E. Berens, and G. Martz (eds.), Predictive Drug Testing on human tumor Cells, pp. 220-223. Heidelberg: Springer-Verlag,1984.
11. Carey, T., Takahashi, T., Resnick, L. A., Oettgen, H. F., and Old, L. J. Cell surface antigens of human malignant melanoma: mixed hemadosorption as says for humoral immunity to cultured autologous melanomacells. Proc. Nati. Acad. Sci. USA, 73: 3278-3282,1976.
12. Sykes, J. A., Whitescarver,J., Jemstrom, P., and Nolan, J. F. Some properties of a new epithelialcell line of humanorigin. J. Natl. Cancer Inst., 45:107-122, 1970.
13. Palliilo, R. A., Hussa, R. O., Story, M. T., Ruckert, A. C. F., Shalaby, M. R., and Mattingly, R. F. Tumor antigenand humanchorionicgonadotropinin CaSkicells: a new epidermoid cervical cancer line. Science (Wash. DC), 796: 1456-1458, 1977.
14. Soule, H. D., Vasquez, J., Long, A., Albert, S., and Brennan, M. A humancell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 57: 1409-1413,1973.
15. Fogh,J., and Trempe, G. New human tumor cell lines. In: J. Fogh(ed.), Human Tumor Cells in Vitro, pp. 115-159. New York: PlenumPublishingCorp., 1975.
16. Kuramoto, H., Tamura, S., and Notake, U. Establishment of a cell line of uman endometrial adenocarcinoma in vitro. Am. J. Obstet. Gynecol., 774: 1012-1019,1972.
17. Matsuoka, Y., Moore, G. E., Yagi, Y., and Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med., 725: 1246-1250,1967.
18. Hamburger,A. W., and Salmon, S. E. Primary bioassay of human tumor stem cells. Science(Wash. DC), 797: 461-463,1977.
19. Kressner, B. E., Morton, R. R. A., Mertens, A. E., Salmon, S. E., Von Hoff, D.D., and Soehnlen, B. Use of an image analysis system to count colonies in stem cell assays of human tumors. In: S. E. Salmon (ed.), Cloning of Human Tumor Stem Cells, pp. 179-193. New York: Alan R. Liss, Inc., 1980.
20. Sundstrom, C., and Nilsson, K. Establishment and characterization of a human histiocytic lymphomacell line (U-937). Int. J. Cancer, 77: 565-577,1976.
21. Welander, C. E., Natale, R. B., and Lewis, J. L., Jr. In vitro growth stimulation of human ovarian cancer cells by xenogeneic peritonealmacrophages. J. Natl. Cancer Inst., 69: 1039-1047,1982.
22. Koski, L. R., Poplack, D. F., and Blaese, R. M. A non specific esterase stain for the identification of monocytes and macrophages.In: B. R. Bloom and J. R. David(eds.), In Vitro Methods in Cell Mediated and Tumor Immunity,pp. 359-362. New York: Academic Press, 1976.
23. Ratliff, T. L., Kadmon, D., Shapiro, A., Jacobs, A. J., and Heston, W. D. W. Inhibition of mouse bladder tumor proliferation by murine interferon-7 and its synergism with interferon-0. Cancer Res., 44: 4377-4381, 1984.
24. Stone-Wolff, D. S., Yip, Y. K., Kelker, H. C., Junming, L. E., Henriksendestefano, D., Rubin, B. Y., Rinderknecht, E., Aggarwal, B. B., and Vilcek, J. Inter relationshipsof human Interferon-βWith lymphotoxin and monocyte cytotoxin. J. Exp. Med., 759: 828-843,1984.
25. Thompson, M. R., Zhang, Z., Foumier, A., and Tan, Y. H. Characterization of humanbeta Interferon binding sites on human cells. J. Biol. Chem., 260: 563-567,1985.
26. Bradley, E. C., Carino, J. J., Issell, B. F., Poiesz, B., Hustad, J. M., Dalton, T., Allegretla, M., and Mier, J. Cell-mediatedinhibition of tumor colony formation in agarose by resting and interleukin2-stimulatedhumanlymphocytes. Cancer Res., 45: 1464-1468,1985.
27. Pace, J. L., Russell, S. W., Schreiber, R. D., Altman, A., and Katz, D. H. Macrophageactivation: priming activity from a T-cell hybridoma is attributable to interferon-T. Proc. Nati. Acad. Sci. USA,80: 3782-3786,1983.
28. Herberman, R. B., Ortldo, J. R., Djeu, J. Y., Holden, H. T., Jett, J. R., Lang, N. P., Rubinstein, M., and Pestaka, S. Role of interferon on regulation of cytotoxicity by natural killer cells and macrophage. Ann. NY Acad. Sci., 350:63-71,1980.
29. Jett, J. R., Mantovani, A., and Herberman, R. B. Augmentation of human monocyte-mediatedcytolysis by interferon. Cell. Immunol.,54:425-434,1980.
30. Salmon, S. E., and Hamburger, A. W. Immuno proliferation and cancer: a common macrophage-derived promotor substance. Lancet,1: 1289-1290, 1978.
31. Celada, A., Gray, P. W., Rinderknecht, E., and Schreiber, R. D. Evidence for GAMA-interferroenceptor that regulates macrophage tumoricidal activity. J. Exp. Med., 760:55-74,1984.
32. Sikora, K. (ed.). Interferon and Cancer. New York: Plenum PublishingCorp., 1983.
33. Mantovani, A., Peri, G., Polentarutti, N., Bolis, G., Mangione,C., and Spreafico, F. Effect on in vitro tumor growth of macrophagesisolated from humanascitic ovarian tumors. Int. J. Cancer, 23:157-164,1979.
34. Gutterman, J. U., Rosenblum, M. G., Rios, A., Pritsche, H. A., and Quesada, J. R. Pharmacokinetic study of partially pure-βinterferonin cancer patients. Cancer Res., 44: 4164-4171,1984.